Related Experiment Videos
Signal transduction by Ras-like GTPases: a potential target for anticancer drugs
M Spaargaren1, J R Bischoff, F McCormick
1ONYX Pharmaceuticals, Richmond, CA 94806, USA.
Abstract:
Members of the ras family of GTPases are involved in a wide variety of cellular processes including cell proliferation, differentiation, apoptosis, and transformation. The ras oncogene is one of the most frequently mutated genes in human cancer. In addition, other oncogene and tumor suppressor gene products are components of the signal transduction pathways in which Ras or other Ras-like GTPases play key regulatory functions. Current progress in the elucidation of these signal transduction pathways will be reviewed and the potential use of these insights for the development of novel therapeutic agents for the treatment of cancer will be discussed.
Insights
Ras GTPases regulate crucial cell functions and are implicated in cancer. Understanding their signaling pathways offers potential for developing new cancer therapies.
Area of Science:
- Molecular Biology
- Oncology
- Cellular Signaling
Background:
- Ras GTPases are key regulators of cellular processes like proliferation and differentiation.
- The ras oncogene is frequently mutated in human cancers, highlighting its role in tumorigenesis.
- Ras-mediated signal transduction pathways involve numerous oncogenes and tumor suppressor genes.
Purpose of the Study:
- To review current understanding of Ras-related signal transduction pathways.
- To discuss the therapeutic potential of targeting these pathways for cancer treatment.
Main Methods:
- Literature review of studies on Ras signaling.
- Analysis of oncogene and tumor suppressor gene involvement.
- Discussion of therapeutic strategies based on pathway elucidation.
Main Results:
- Ras GTPases control fundamental cellular activities.
- Mutations in ras genes are common drivers of human cancers.
- Elucidation of these pathways is crucial for cancer research.
Conclusions:
- Understanding Ras signaling pathways is vital for advancing cancer therapy.
- Targeting Ras-related pathways holds promise for novel cancer treatments.